Activation of the urotensin II (U-II) receptor, GPR14, leads to an increase in Ca 2+ , activation of phospholipase A 2 (PLA 2 ) and an increase in arachidonic acid. The signaling pathway for guanylin peptides in the kidney involves an unknown G-protein coupled receptor which activates PLA 2 and increases arachidonic acid as well. To test if guanylin peptides could be, as U-II, agonists for the GPR14 receptor in the kidney, we used HEK293 and CHO cells transfected with hGPR14 (HEK293+hGPR14, CHO+hGPR14, respectively). Effects of guanylin peptides and U-II were studied by slow-whole-cell patch-clamp analysis and microfluorimetric measurements of intracellular Ca
Introduction
Urotensin (U-II) is a hexapeptid with one disulfide bond [1] . U-II vasoactivity differs between species and vascular beds [2] . U-II is highly expressed in the human kidney [3, 4] and causes natriuresis and vasodilations in rat kidney [5] . U-II is a ligand for the G-protein coupled receptor (GPR14) [6] . An activation of GPR14 leads to activation of phospholipase C (PLC), an increase in 182 intracellular Ca 2+ , and activation of phospholipase A 2 (PLA 2 ) with an increase in cellular arachidonic acid [7] . mRNA for human GPR14 is expressed in human heart, kidney, brain, pancreas, skeletal muscle, vacular smooth muscle, endothelial cells, spinal cord and endocrine tissue [3, 7, 8] . This wide distribution of GPR14 suggests that U-II may have an endocrine function or GPR14 serves as receptor for other hormones.
Possible additional ligands for the GPR14 receptor could also be guanylin and uroguanylin (guanylin peptides). The intestine secretes guanylin peptides [9] which causes natriuresis, kaliuresis, and diuresis in the kidney [10] [11] [12] . In the intestine guanylin peptides regulate water and electrolyte transport via guanylate cyclase C (GC-C). However, in GC-C deficient mice (GC-C -/-) guanylin peptides still cause natriuresis, kaliuresis, diuresis and increased urinary cGMP levels. This suggests the existence of at least one additional signaling pathway in the kidney for guanylin peptides which is GC-C independent [12] . In a human proximal tubule cell line (IHKE1), we recently demonstrated that UGN activates two signaling pathways: one involving GC-C leading to an increase in cellular cGMP; the other involves the activation of a pertussis toxin (PT)-sensitive G-protein [13] . Results from principal cells of mouse and human cortical collecting ducts (CCD) suggest the existence of another signaling pathway for guanylin peptides involving the activation of phospholipase A 2 (PLA 2 ) and arachidonic acid [14, 15] .
Therefore we examined if guanylin peptides activate GPR14 and thereby mediate the effects observed in the kidney. This was tested in human embryonic kidney cells (HEK293) and chinese hamster ovary cells (CHO) as expression systems, both transfected with the human GPR14 receptor.
Materials and Methods
Cell culture HEK293 cells transfected with human GPR14 (kindly provided by Sanofi-Aventis, Höchst, Germany) as shown previously [16] were cultured on glass cover slips in DMEM with 3.7 g/L NaHCO 3, 2 mM L-glutamine, 10 ml/l Penicilin/ Streptomycin (10000 U/10000 µg/ml, Biochrom), 12 ml/l Geneticin (50mg/ml, Gibco, (Karlsruhe, Germany) and 10% FCS in an atmosphere with 8% CO 2 at 37°C. The HEK293 WT cells were kept in the same media with the exception of geneticin. The cells were used 5-12 days after trypsination (0.05% trypsin, 0.02% EDTA in Mg² + -and Ca² + -free phosphate buffer). CHO-K1 cells transfected with human GPR14 [17] (kindly provided by Actelion Ltd., Allschwil/Basel, Switzerland) were cultured on glass cover slips in Iscoves medium with 3.0 g/L NaHO 3, 15 mg/L phenolred supplemented with 200 mM Lglutamine, 5 ml/l Penicillin/Streptomycin (10000 U/10000 µg/ml, Biochrom), geneticin (50 mg/ml), 50 ml of 10% fetal calf serum in an atmosphere with 8% CO 2 at 37°C. The CHO WT cells were kept in the same media only without geneticin. The cells were used 4 days after trypsination (0.25% trypsin, 0.1% EDTA in Mg 2+ -and Ca
2+
-free phosphate buffer).
Patch-clamp technique
Coverslips with HEK293 or CHO cell monolayers were mounted at the bottom of a perfusion chamber of an inverted microscope (Axiovert 10, Zeiss, Göttingen, Germany). Membrane voltages were measured with the slow-whole-cell patch-clamp technique [18] [19] . The involvement of PLA 2 and PKC in the regulation of the GPR14 receptor was determined using the specific inhibitors AACOCF 3 (5 µM) and calphostin C (100 nM), respectively. To determine whether the effects of U-II and UGN are dependent on intracellular Ca 2+ stores thapsigargin (1 µM) was used. The involvement of the GPR14 receptor in the signaling pathway of U-II and UGN was further tested using BIM-23127 and urantide, both inhibitors of this receptor [20, 21] .
RT-PCR
Nephron segments were isolated using the procedure described previously [22, 23] . In brief, cortical pieces of mouse and human kidney were incubated in modified Eagle´s medium (MEM) containing 5 mM glycin, 480 IU/ml trypsin inhibitor from soybean, 50 IU/ml DNAse, 178 IU/ml and 533 IU/ml collagenase type 2 (Worthington Biochemical Corp., New Jersey, USA) for mouse and human kidney, respectively, for 60 -100 min at 37°C with aeration (95% O 2 and 5% CO 2 ). Specific nephron segments were collected in MEM with 5 mM glycin under 50 x magnification at 4°C.
Cortical pieces of human kidney, isolated nephron segments (approximately 40 mm), glomeruli (400 pieces) or HEK293+hGPR14 cells were lyzed in a 4 M guanidium chloride buffer and total RNA was isolated using the RNeasy kit (Qiagen, Hilden, Germany). cDNA was synthesized by reverse transcriptase (Promega, Heidelberg, Germany) and subjected to PCR reactions. For detecting mRNA for GPR14 the primers 5´-CTGGTGCTGGGCATCGTGCT-3´ and 5´-AGGTGGTCECGGTAGTCC-3´ (product size of 203 bp, annealing temperature of 64 o C) were used. For detecting mRNA for GPR14 in mouse nephron segments the primers 5'-CCT ATT GGC TAT CCC AGA AA-3' and 5'-AGC AAG AAG CTA CCG TGG AA-3' (product size of 851 bp, annealing temperature of 64°C) were used. GAPDH expression was used as a positive control. PCR reaction products were analyzed by agarose gel electrophoresis and verified by sequence analysis (Sequence Laboratories, Göttingen, Germany).
Western blot
Whole kidneys from male C57BL mice were homogenized in 25 mM Tris-HCl, 1 mM NaVO 3 , 1 mM EDTA, 1% SDS, and protease inhibitors. HEK293 cells transfected with the human GPR14 receptor were solubilized with the same solution to which 15% (w/v) Triton X-100 was added. Proteins were separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to a PVDF membrane incubated with blocking agent (Amersham, Freiburg, Germany). A goat polyclonal antibody directed against the C-terminal part of the ROMK channel was used (Santa Cruz Biotechnology, Santa Cruz, CA, USA). Peroxidase-conjugated anti-goat secondary antibody was used and visualized by super signal cheminoluminescent detection (Perbio Science, Bonn, Germany).
Fluorescence measurements of intracellular Ca

2+
To measure the intracellular Ca 2+ concentrations of HEK293 cells, the Ca 2+ -sensitive dye fura 2 was used [24] . The cells were incubated with the acetomethyl ester (fura2-AM; 5µM) dissolved with 0.1 g/l pluronic F-127 in standard solution for 45 min at 37°C in the dark and excited at 340, 360, and 380 nm. Fluorescence was detected at 500 to 530 nm with a single photon-counting-tube (H3460-04; Hamamatsu, Herrsching, Germany). The ratio of the emissions after excitations at 340 and 380 nm was calculated. The signal at 360 nm was used as Ca 2+ independent control.
Biochemical Reagents
MEM was obtained from Gibco, human GN and UGN from Peptide Institute (Osaka, Japan), and AAC OCF 3 was purchased from Biomol (Hamburg, Germany), all other chemicals from Merck (Darmstadt, Germany) or Sigma (Taufkirchen, Germany).
Statistical Analyses
Student´s unpaired t-test was used when effects between transfected cells and WT cells were compared. When the effects between more than two groups were tested, ANOVA with Tukey as post test was used. Data are presented as mean values ± SEM. The number of experiments is given in brackets. P < 0.05 was set as significance level. (Table 1) .
Results
General characteristics of used cells
CHO WT cells were used from passages 8 to 14, 4-6 days after trypsination. CHO cells transfected with hGPR14 (CHO+hGPR14) were used from passages 9 to 15, 4-6 days after trypsination. Basal V m and depolarizations caused by increasing the extracellular K + concentration were not significantly different between WT and CHO+hGPR14 cells (table 1) . In CHO+hGPR14 cells the inhibitor of PLA 2 (1 µM) interestingly caused hyperpolarizations while the same inhibitor caused depolarizations in HEK293+hGPR14 cells, suggesting different downstream targets between the two expression systems.
Effects of guanylin peptides and urotensin II on V m
To test if GPR14 is a possible receptor for guanylin peptides we used two cell types transfected with hGPR14. Guanylin peptides (10 nM each) and urotensin II (50 pM), a well known agonist for GPR14 [6] , caused significantly higher depolarizations in HEK293+hGPR14 cells than in HEK293 WT cells ( figure 1A ). In contrast in CHO+hGPR14 cells guanylin peptides did not significantly increase depolarizations also observed in CHO WT cells. Compared to guanylin peptides, urotensin II (U-II) caused different effects in CHO cells, as it depolarized WT and hyperpolarized transfected cells ( figure 1B ). This different behavior of guanylin peptides and U-II in HEK293+hGPR14 and CHO+hGPR14 cells could be due to different expression of proteins involved in GPR14 down stream signaling. Therefore, we used two GPR14 inhibitors: BIM-23127 [20] and urantide [21] . The effects of UGN and U-II (10 nM) in HEK293+hGPR14 and CHO+hGPR14 cells were inhibited by BIM-23127 (1 µM) confirming the activation of the GPR14 receptor by guanylin peptides and U-II (figure 2). However, urantide (0.3 and 1 µM), did not inhibit the UGN effects in HEK293+hGPR14 cells but still inhibited the U-II ef- fects in these cells.
Guanylin peptides modified the membrane potential of mouse and human principal cells of cortical collecting ducts [14, 15] and proximal tubules by changing the K + conductance [13] . In effects of guanylin peptides or U-II on HEK-GPR14 cells is the ROMK channel, as this channel was already suggested as target for guanylin peptides in cortical collecting ducts [14, 15] . It is known that ROMK channels are present in HEK293 wild type cells [25] . Using western blot analysis we were able to show the presence of ROMK channels also in HEK293+hGPR14 cells used in this study. Lysates of mouse whole kidney were used as positive control for ROMK expression (figure 4).
Involvement of PLA 2 in signaling pathways
To test if ROMK and arachidonic acid are involved in the signaling pathway of guanylin peptides and U-II, we used AACOCF 3 , an inhibitor of PLA 2 . In [17] and HEK293+hGPR14 cells [16] . In this study only U-II (10 nM), but not GN and UGN (each 10 nM) increased intracellular Ca in HEK293+GPR14 cells. In these experiments ATP was used as positive control (figure 6).
To further investigate which part of the Ca 2+ signaling pathway is involved in these cells we used thapsigargin, which inhibits Ca To understand why guanylin peptides did not increase Ca 
Expression of GPR14 receptor
Expression of mRNA for the GPR14 receptor was detected using RT PCR. The GPR14 receptor was expressed in mouse proximal tubules and cortical collecting ducts (CCD) and in human kidney cortex and human CCD ( figure 9 ). HEK293+hGPR14 cells were used as a positive control. concentrations. The number of experiments is given in brackets. Fig. 9 . Expression of GPR14 in mouse (A) and human (B) kidney. A: M = marker, 1=glomeruli, 2=proximal tubules, 3=cortical thick ascending limbs, 4=cortical collecting ducts, 5=neg. control (no cDNA), 6=pos. control (GAPDH). B: M=marker, 1=kidney cortex, 2=cortical collecting ducts, 3=HEK293+hGPR14 cells, 4=neg. control (no cDNA), 5=pos. control (GAPDH).
Discussion
The signaling pathway for guanylin peptides in principal cells of human and mouse cortical collecting ducts involves an activation of PLA 2 and an increase of intracellular arachidonic acid [14, 15] . So far no data exist on the molecular identity of possible receptors for guanylin peptides besides the GC-C, although evidence for the existence of another receptor is available, especially from GC-C deficient mice. Since it is known that activation of the G-protein coupled receptor GPR14 also leads to activation of PLA 2 and to an increase of cellular arachidonic acid [7] , we have investigated whether the GPR14 receptor, which is expressed in mouse and human CCD (figure 9), may be involved in the signaling pathway of guanylin peptides in the expression systems HEK293 and CHO cells stably transfected with the human GPR14 receptor.
Our results show that guanylin and uroguanylin depolarized transfected HEK293 cells significantly higher than wild type cells ( figure 1 ). This depolarization of HEK293 cells caused by both peptides was due to [23] and is involved in the signaling of guanylin peptides [14, 15] . As ROMK channels are also expressed in HEK293 cells, GPR14 is also a likely candidate as target for guanylin peptides and U-II in this expression system of renal origin (figure 4). In contrast to HEK293+hGPR14 cells, CHO cells transfected with the same receptor showed no difference in the depolarizations caused by guanylin peptides compared to WT cells. While the effects of U-II in HEK293+hGPR14 cells led to depolarizations, it caused hyperpolarizations in CHO+hGPR14 cells, suggesting either a different signaling pathway or a different final target for U-II in HEK293 cells compared to CHO cells. U-II effects in CHO cells were also independent of K + channel activity, again in contrast to the effects of GN and UGN. Thus, In HEK293 cells, U-II, GN, and UGN seem to have activated the same signaling pathway, leading to electrogenic conductance effects while in CHO cells such an electrogenic effect cannot be seen. This would most likely be due to differences in the signaling cascade downstream of possible receptor activation.
To further clarify the difference in activation of GPR14 in the two expression systems, we used potential GPR14 inhibitors. Figure 2A shows that the UGN effects were significantly inhibited by BIM-23127 in HEK293+hGPR14 cells. However, the more recently described antagonist of GPR14 urantide only blocked the effects of U-II but not of UGN. Assuming that urantide is a more specific inhibitor of the GPR14 receptor, this would suggest that guanylin peptides activate a similar signaling pathway as U-II in HEK293 cells but this does not necessarily involve the GPR14 receptor. Alternatively, one would have to postulate different binding sites for U-II and guanylin peptides at this receptor, of which only the U-II binding site is inhibited by urantide. As expected both inhibitors diminished hyperpolazations of CHO+hGPR14 cells caused by U-II (figure 2B). In CHO cells guanylin peptides did apparently not activate the GPR14 receptor, although it cannot be excluded that the receptor and the signaling cascade was activated by these hormones, however, this activation does not lead to changes in electrogenic transporters or ion channels (see also below).
As reported before, activation of GPR14 leads to an increase in intracellular Ca 2+ and activation of PLA 2 which leads to an increase in cellular arachidonic acid [19] . To test the involvement of arachidonic acid in the signaling pathway of the tested hormones in HEK293+hGPR14 cells, we used AACOCF 3 , a selective inhibitor of PLA 2 [26] . Stimulation of PLA 2 sets free arachidonic acid from plasma membrane phospholipids. The depolarizations caused by UGN (10 nM) or U-II (50 pM) on HEK293+hGPR14 cells were indeed inhibited by AACOCF 3 (1 µM). This suggests again the involvement of PLA 2 , arachidonic acid and consequently probably ROMK channels in the signaling pathway of U-II and UGN in these renal cells. Interestingly, at a concentration of 5 µM AACOCF 3 reversed the depolarizations caused by U-II into hyperpolarizations. These results suggest the existence of two signaling pathways for U-II in HEK293+hGPR14 cells ( figure 5A ). The predominant effect is the PLA 2 -dependent depolarization while the hyperpolarization can only be unmasked when the other pathway is inhibited. The hyperpolarization is due to an activation of a K + conductance as it was also blocked by Ba 2+ (figure 7B). AACOCF 3 had no influence on hyperpolarizations of CHO+hGPR14 cells caused by U-II (figure 5B) which again suggest a different mechanism of U-II downstream signaling in these two different expression systems transfected with the same receptor.
Furthermore U-II also increased intracellular Ca 2+ in HEK293+hGPR14 cells [16] . Thus, we tested whether Ca 2+ could be involved as second messenger in the PLA 2 -independent effects of guanylin peptides in transfected HEK293 cells. Thapsigargin, which inhibits the Ca 2+ release from the endoplasmatic reticulum by blocking Ca 2+ -ATPases, inhibited the hyperpolarizations caused by U-II, suggesting an involvement of this signaling pathway in the hyperpolarizations induced by U-II. As inhibition of PKC by calphostin C also inhibited the hyperpolarizations induced by U-II, we can conclude that this second effect of U-II involves a Ca figure 7C ).
In conclusion, in the renal expression system HEK293 cells guanylin peptides depolarized cells by activating PLA 2 which increases the intracellular concentration of arachidonic acid and inhibits ROMK channels. Whether GPR14 is the only G-protein coupled receptor activated by guanylin peptides and leading to an activation of PLA 2 also in the renal collecting duct remains to be proven further. Urotensin II is still the most potent agonist of the GPR14 receptor. However, the signaling pathway for U-II in HEK293 cells and CHO cells expressing GPR14 is significantly different. In CHO cells a PLA2 dependent signaling pathway activated via GPR14
was not detected . The only pathway for urotensin II that exists in CHO cells is Ca 2+ dependent.
